CH626379A5 - - Google Patents

Download PDF

Info

Publication number
CH626379A5
CH626379A5 CH910976A CH910976A CH626379A5 CH 626379 A5 CH626379 A5 CH 626379A5 CH 910976 A CH910976 A CH 910976A CH 910976 A CH910976 A CH 910976A CH 626379 A5 CH626379 A5 CH 626379A5
Authority
CH
Switzerland
Prior art keywords
derivative
formula
double bond
defined above
halogen
Prior art date
Application number
CH910976A
Other languages
German (de)
English (en)
Inventor
Arthur Friedrich Marx
Nicolaa Cornelis Mari Barendse
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of CH626379A5 publication Critical patent/CH626379A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH910976A 1975-07-16 1976-07-15 CH626379A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29898/75A GB1550343A (en) 1975-07-16 1975-07-16 Androstane derivatives

Publications (1)

Publication Number Publication Date
CH626379A5 true CH626379A5 (xx) 1981-11-13

Family

ID=10298992

Family Applications (1)

Application Number Title Priority Date Filing Date
CH910976A CH626379A5 (xx) 1975-07-16 1976-07-15

Country Status (20)

Country Link
US (1) US4075233A (xx)
JP (1) JPS5212159A (xx)
AT (1) AT362085B (xx)
AU (1) AU506101B2 (xx)
BE (1) BE844169A (xx)
CH (1) CH626379A5 (xx)
DE (1) DE2631915A1 (xx)
DK (1) DK142877B (xx)
FI (1) FI55851C (xx)
FR (1) FR2317934A1 (xx)
GB (1) GB1550343A (xx)
HU (1) HU175369B (xx)
IE (1) IE43693B1 (xx)
IT (1) IT1063150B (xx)
LU (1) LU75394A1 (xx)
NL (1) NL7607824A (xx)
NO (1) NO146865C (xx)
NZ (1) NZ181482A (xx)
SE (1) SE7608092L (xx)
ZA (1) ZA764195B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1566905A (en) * 1977-03-28 1980-05-08 Gist Brocades Nv Steroids of the a-nor-androstane and a-nor-estrane series
DE3115995A1 (de) * 1981-04-13 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen D-homo-4,17-androstadien-3-on, verfahren zu seiner herstellung und diese verbindung enthaltende pharmazeutische praeparate
JPS58185406A (ja) * 1982-04-20 1983-10-29 Mitsubishi Gas Chem Co Inc 過硼酸塩の製造方法
EP0133995B1 (en) * 1983-08-02 1992-04-15 Research Corporation Technologies, Inc. Steroids and therapeutic compositions containing same
DE3514272A1 (de) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen Dermatica
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
ES2210243T3 (es) * 1993-06-15 2004-07-01 Pherin Corporation Esteroides de androstano utiles como iniciadores del cambio de la funcion hipotalamica humana, composiciones farmaceuticas y procedimientos asociados.
US6331534B1 (en) 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
CN112778390B (zh) * 2021-01-22 2022-09-30 厦门欧瑞捷生物科技有限公司 一种雄烯酮的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501462A (en) * 1966-05-02 1970-03-17 Sterling Drug Inc 17-cyclopropyl steroids

Also Published As

Publication number Publication date
DK142877B (da) 1981-02-16
JPS5212159A (en) 1977-01-29
AT362085B (de) 1981-04-27
FI55851C (fi) 1979-10-10
IT1063150B (it) 1985-02-11
NZ181482A (en) 1978-12-18
FI55851B (fi) 1979-06-29
NO146865C (no) 1982-12-22
SE7608092L (sv) 1977-01-17
GB1550343A (en) 1979-08-15
BE844169A (fr) 1977-01-17
AU506101B2 (en) 1979-12-13
IE43693L (en) 1977-01-16
ZA764195B (en) 1977-07-27
AU1593876A (en) 1978-01-19
LU75394A1 (xx) 1977-02-28
DK142877C (xx) 1981-09-28
DK321676A (xx) 1977-01-17
NL7607824A (nl) 1977-01-18
FR2317934A1 (fr) 1977-02-11
ATA519776A (de) 1980-09-15
IE43693B1 (en) 1981-05-06
US4075233A (en) 1978-02-21
NO146865B (no) 1982-09-13
FI762058A (xx) 1977-01-17
DE2631915A1 (de) 1977-02-03
FR2317934B1 (xx) 1980-11-07
HU175369B (hu) 1980-07-28
NO762483L (xx) 1977-01-18

Similar Documents

Publication Publication Date Title
CH626379A5 (xx)
EP0277089B1 (de) 11 Beta-alkinyl-estrene und -estradiene, deren Herstellung und diese enthaltende pharmezeutische Präparate
DE1443683C3 (de) 7alpha Methyl 17alpha athinyl östradiol und sein 3 Methylather, Ver fahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE69016627T2 (de) Neue Steroidderivate, die ein substituiertes Ethylradikal an der Stelle 10 des Steroids tragen, Verfahren zu ihrer Herstellung, die Verwendung als Arzneimitte, von einer dieser Verbindungenl und pharmazeutische Präparate von dieser Verbindung.
CH635594A5 (de) Verfahren zur herstellung von neuen gona-4,9(10)-dienen.
EP0100874A2 (de) Neue 6,16-Dimethylkortikoide, ihre Herstellung und Verwendung
DE1232138B (de) Verfahren zur Herstellung von delta 5-6-Methylsteroiden
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE3539244A1 (de) 1-methyl-15(alpha)-alkyl-androsta- 1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE1947221A1 (de) 3-Aza-19-hydroxy-3,19-cyclo-A-homosteroide und ein Verfahren zu deren Herstellung
EP0019247A1 (de) 16-Alpha-Alkylsteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP1409513B1 (de) Methylen-4-azasteroide
DE2602891A1 (de) Neue 13-aethinyl-steroide und verfahren zu ihrer herstellung
DE2119708C3 (de) 4,14-Östradiene, Verfahren zu ihrer Herstellung und diese enthaltende Arzneipräparate
AT233177B (de) Verfahren zur Herstellung des neuen 6α-Methyl-17 α-hydroxyprogesterons und seiner Ester
EP0000368B1 (de) D-Homosteroide und solche enthaltende Präparate sowie Verfahren zur Herstellung solcher D-Homosteroide
DD251142A1 (de) Verfahren zur herstellung von 16 alpha, 17 alpha-cyclohexano-17 beta-acetylgonen-3-onen
DE2651364A1 (de) Neue d-homosteroide
AT220764B (de) Verfahren zur Herstellung von neuen 3-Oxo-Δ<1,4>-6-methyl- und 3-Oxo-Δ<1,4,6>-6-methylsteroiden
DE1493114C3 (xx)
DE1176131B (de) Verfahren zur Herstellung von 16-Cyan- und 16-Cyan-16, 17-seco-steroiden
DE19709870A1 (de) Cycloalkylsteroide, Verfahren zu ihrer Herstellung und Anwendung derselben
EP0218647A1 (de) Dermatica.
DE2533496A1 (de) Neue difluorsteroide und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
PL Patent ceased